Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies
对于存在抗利妥昔单抗抗体的膜性肾病患者,奥妥珠单抗和奥法妥木单抗比利妥昔单抗更有效。
期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2024.12.012
Teisseyre, Maxime; Allinovi, Marco; Audard, Vincent; Cremoni, Marion; Belvederi, Giulia; Karamé, Alexandre; Accinno, Matteo; Duquesne, Julien; Sharma, Vinod; Fernandez, Céline; Zorzi, Kévin; El Maï, Mounir; Brglez, Vesna; Benzaken, Sylvia; Esnault, Vincent L M; Vultaggio, Alessandra; Kohli, Harbir Singh; Ramachandran, Raja; Cirami, Calogero Lino; Seitz-Polski, Barbara